Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Céline Labeyrie

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
Journal of Neurology, Neurosurgery, and Psychiatry|October 24, 2023
Detailed clinical, physiological and pathological phenotyping can impact access to disease-modifying treatments in ATTR carriersDiane Beauvais, Céline Labeyrie, Cécile Cauquil, et al.
Bulletin Du Cancer|December 11, 2019
[Indication of autologous stem cell transplantation in chronic inflammatory demyelinating polyneuropathy: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]Mathieu Puyade, Céline Labeyrie, Manuela Badoglio, et al.
Annals of Medicine|June 30, 2025
Diagnostic pathway for cardiac amyloidosis from the healthcare professional's perspective: results from the French DIAM-ATTR surveySilvia Oghina, Damien Legallois, Fabien Hyafil, et al.
European Journal of Neurology|April 22, 2025
TTR Gene Screening Since the Advent of Biotherapies in France: A Nationwide Retrospective Survey Between 2018 and 2023Abd El Kader Ait Tayeb, Pauline Chazelas, Vianney Poinsignon, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|March 6, 2020
Quality of life outcomes in APOLLO, the phase 3 trial of the RNAi therapeutic patisiran in patients with hereditary transthyretin-mediated amyloidosisLaura Obici, John L Berk, Alejandra González-Duarte, et al.
Bulletin Du Cancer|November 28, 2017
[Indications and follow-up for autologous hematopoietic stem cell transplantation in autoimmune and autoinflammatory diseases: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]Grégory Pugnet, Christina Castilla-Llorente, Mathieu Puyade, et al.
European Journal of Neurology|August 15, 2022
Anti-disialosyl-immunoglobulin M chronic autoimmune neuropathies: a nationwide multicenter retrospective studyClaire Peillet, David Adams, Shahram Attarian, et al.
Brain Communications|October 15, 2021
Neurological complications induced by immune checkpoint inhibitors: a comprehensive descriptive case-series unravelling high risk of long-term sequelaeLéo Plaçais, Jean-Marie Michot, Stéphane Champiat, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|October 19, 2023
Hereditary transthyretin amyloidosis in middle-aged and elderly patients with idiopathic polyneuropathy: a nationwide prospective studyGuillaume Fargeot, Andoni Echaniz-Laguna, Céline Labeyrie, et al.
Kidney International Reports|July 9, 2025
Kidney Outcomes in Patients With Hereditary Transthyretin Amyloid Nephropathy Treated With Transthyretin Stabilizers And Gene-Silencer TherapiesJulien Dang, Justine Solignac, Sophie Ferlicot, et al.
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
Journal of Neurology, Neurosurgery, and Psychiatry|October 24, 2023
Detailed clinical, physiological and pathological phenotyping can impact access to disease-modifying treatments in ATTR carriersDiane Beauvais, Céline Labeyrie, Cécile Cauquil, et al.
Bulletin Du Cancer|December 11, 2019
[Indication of autologous stem cell transplantation in chronic inflammatory demyelinating polyneuropathy: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]Mathieu Puyade, Céline Labeyrie, Manuela Badoglio, et al.
Annals of Medicine|June 30, 2025
Diagnostic pathway for cardiac amyloidosis from the healthcare professional's perspective: results from the French DIAM-ATTR surveySilvia Oghina, Damien Legallois, Fabien Hyafil, et al.
European Journal of Neurology|April 22, 2025
TTR Gene Screening Since the Advent of Biotherapies in France: A Nationwide Retrospective Survey Between 2018 and 2023Abd El Kader Ait Tayeb, Pauline Chazelas, Vianney Poinsignon, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|March 6, 2020
Quality of life outcomes in APOLLO, the phase 3 trial of the RNAi therapeutic patisiran in patients with hereditary transthyretin-mediated amyloidosisLaura Obici, John L Berk, Alejandra González-Duarte, et al.
Bulletin Du Cancer|November 28, 2017
[Indications and follow-up for autologous hematopoietic stem cell transplantation in autoimmune and autoinflammatory diseases: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]Grégory Pugnet, Christina Castilla-Llorente, Mathieu Puyade, et al.
European Journal of Neurology|August 15, 2022
Anti-disialosyl-immunoglobulin M chronic autoimmune neuropathies: a nationwide multicenter retrospective studyClaire Peillet, David Adams, Shahram Attarian, et al.
Brain Communications|October 15, 2021
Neurological complications induced by immune checkpoint inhibitors: a comprehensive descriptive case-series unravelling high risk of long-term sequelaeLéo Plaçais, Jean-Marie Michot, Stéphane Champiat, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|October 19, 2023
Hereditary transthyretin amyloidosis in middle-aged and elderly patients with idiopathic polyneuropathy: a nationwide prospective studyGuillaume Fargeot, Andoni Echaniz-Laguna, Céline Labeyrie, et al.
Kidney International Reports|July 9, 2025
Kidney Outcomes in Patients With Hereditary Transthyretin Amyloid Nephropathy Treated With Transthyretin Stabilizers And Gene-Silencer TherapiesJulien Dang, Justine Solignac, Sophie Ferlicot, et al.
Pageof 5